# Optimizing the Management of Acute Diarrhoeal Disease

> **NCT02803827** · PHASE3 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 276 (actual)

## Conditions studied

- Acute Gastroenteritis

## Interventions

- **OTHER:** Rapid diagnostics
- **BIOLOGICAL:** Probiotic
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02803827
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2019-01
- **Final completion:** 2019-02
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02803827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02803827, "Optimizing the Management of Acute Diarrhoeal Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02803827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*